Insider Shareholders with Direct Ownership of Spring Works Therapeutics, Inc. (SWTX)
This section provides a comprehensive overview of the insiders with direct ownership of Spring Works Therapeutics, Inc. (SWTX). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
SpringWorks Therapeutics, Inc. Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
|
Pfizer Inc
> 10% Shareholder |
4,593,847 | 0 | 4,593,847 $216 Million | 1 |
Sep 17, 2019
Added 1.08%
|
|
Jens Renstrup
Chief Medical Officer |
6,075 | 0 | 250,499 $11.8 Million | 1 |
Jan 07, 2021
Added 2.37%
|
|
L. Mary Smith
Chief Development Officer |
128,836 | 52,575 | 233,363 $11 Million | 20 |
Jan 08, 2024
Reduced 1.49%
|
|
Stephen P Squinto
Director |
5,924 | 21,000 | 131,652 $6.19 Million | 6 |
May 19, 2022
Added 3.53%
|
|
Michael F. Burgess
Head of Research & Development |
55,359 | 5,775 | 49,584 $2.33 Million | 5 |
Jul 18, 2022
Reduced 5.89%
|
|
Jeffrey Lawrence Schwartz
Director |
10,572 | 0 | 10,572 $496,778 | 3 |
May 24, 2023
Added 30.54%
|
|
Freda C Lewis Hall
Director |
24,727 | 24,727 | 0 $0 | 6 |
Jul 01, 2025
Reduced 100.0%
|
|
Carlos Alban
Director |
28,861 | 28,861 | 0 $0 | 5 |
Jul 01, 2025
Reduced 100.0%
|
|
Martin Mackay
Director |
20,023 | 20,023 | 0 $0 | 3 |
Jul 01, 2025
Reduced 100.0%
|
|
Daniel Lynch
Director |
24,727 | 316,004 | 0 $0 | 9 |
Jul 01, 2025
Reduced 100.0%
|
|
Alan Fuhrman
Director |
24,727 | 24,727 | 0 $0 | 6 |
Jul 01, 2025
Reduced 100.0%
|
|
Julie Hambleton
Director |
38,501 | 38,501 | 0 $0 | 12 |
Jul 01, 2025
Reduced 100.0%
|
|
Herschel S Weinstein
General Counsel & Secretary |
72,769 | 73,126 | 0 $0 | 14 |
Jul 01, 2025
Reduced 100.0%
|
|
Daniel Pichl
Chief People Officer |
135,695 | 135,906 | 0 $0 | 22 |
Jul 01, 2025
Reduced 100.0%
|
|
Perier I Francis Jr
Chief Financial Officer |
81,169 | 81,708 | 0 $0 | 14 |
Jul 01, 2025
Reduced 100.0%
|
|
Michael Nofi
Chief Accounting Officer |
39,494 | 39,647 | 0 $0 | 14 |
Jul 01, 2025
Reduced 100.0%
|
|
Saqib Islam
Chief Executive Officer |
647,241 | 1,620,690 | 0 $0 | 34 |
Jul 01, 2025
Reduced 100.0%
|
|
Badreddin Edris
Chief Operating Officer |
142,453 | 377,898 | 0 $0 | 21 |
Jul 01, 2025
Reduced 100.0%
|
|
Bhavesh Ashar
Chief Commercial Officer |
91,993 | 91,993 | 0 $0 | 18 |
Jul 01, 2025
Reduced 100.0%
|
|
James Cassidy
Chief Medical Officer |
73,914 | 99,744 | 0 $0 | 14 |
Jul 01, 2025
Reduced 100.0%
|
|
Tai An Lin
Chief Scientific Officer |
36,218 | 36,218 | 0 $0 | 6 |
Jul 01, 2025
Reduced 100.0%
|